Sphere Fluidics unveils next-generation single-cell analysis platform
Cambridge-based Sphere Fluidics has announced the development of Cyto-Mine Chroma, an advanced iteration of its Cyto-Mine platform for single-cell analysis and isolation. Set to launch in Q1 2025, the new system aims to enhance workflow efficiency in biotherapeutic discovery and development.













